actors that could affect Solta Medical's business and its financial results are detailed in its Form 10-K for the year ended December 31, 2011, and other reports as filed from time to time with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. Solta Medical undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
Solta Medical, Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands of dollars, except share and per share data)(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2012201120122011Net revenue
$35,028$27,411$104,744$82,816Cost of revenue
13,8139,51939,73828,300Gross margin
21,21517,89265,00654,516Operating expenses:Sales and marketing
12,40310,78440,02234,517Research and development
4,8493,66515,16710,878General and administrative
4,5574,66913,83212,003Remeasurement of contingent consideration liability
1,900(394)32,600(878)Total operating expenses
23,70918,724101,62156,520Loss from operations
(2,494)(832)(36,615)(2,004)Interest income
319852Interest expense
(377)(16)(1,078)(90)Other income and expense, net
46(306)(101)(188)Loss before income taxes
(2,822)(1,135)(37,786)(2,230)Provision for income taxes
5610177146Net loss
($2,878)($1,145)($37,963)($2,376)Net loss per share — basic and diluted
($0.04)($0.02)($0.60)($0.04)Weighted average shares outstanding used in calculating net loss per share:Basic and diluted
65,947,36160,785,01563,017,22060,443,429 Solta Medical, In
'/>"/>
SOURCE Solta Medical, Inc. Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related medicine technology :1.
Solta Medical And BTL Industries Resolve Patent Dispute2.
Solta Medical to Present at the 32nd Annual Canaccord Growth Conference3.
Solta Medical, Inc. Closes Public Offering of Common Stock4.
Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock5.
Solta Medical, Inc. Announces Proposed Public Offering of Common Stock6.
Solta Medical Reports Second Quarter Results7.
Solta Medical to Present at the JMP Securities Healthcare Conference8.
Solta Medical Reports First Quarter Results9.
OKI Europe Launches Cost-effective DICOM-embedded LED Printer Range - a First for Medical Imaging and Printing10.
MetroStar Home Health Medical Equipment Holds Seven-Day Disaster Relief Drive11.
Vasomedical Retains KCSA Strategic Communications as Corporate Communications Counsel